NRP1 and breast carcinoma: Therefore, we propose that a reduction in miR-29b/miR-338 expression elicited by FOXO3a inactivation results in alleviation of miR-29b/miR-338-mediated targeting of VEGF-A/NRP1, thus contributing to the aggressive behavior of breast cancers.